

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.07334395 |
| 2 | vocalization behavior (GO:0071625) | 5.78304298 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.74867788 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.69642391 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.62604161 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.61994496 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.60438652 |
| 8 | glutamate secretion (GO:0014047) | 5.54363325 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.48556222 |
| 10 | sodium ion export (GO:0071436) | 5.20134033 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.19139442 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.09372659 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.98653737 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.93674701 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.93257102 |
| 16 | protein localization to synapse (GO:0035418) | 4.83624378 |
| 17 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.60801955 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.52591257 |
| 19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.51885249 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.50363373 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.47171809 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.41746009 |
| 23 | cerebellar granule cell differentiation (GO:0021707) | 4.34663432 |
| 24 | exploration behavior (GO:0035640) | 4.32985400 |
| 25 | dendritic spine morphogenesis (GO:0060997) | 4.26516910 |
| 26 | central nervous system myelination (GO:0022010) | 4.24792128 |
| 27 | axon ensheathment in central nervous system (GO:0032291) | 4.24792128 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.21067504 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 4.18135335 |
| 30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.17228662 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.11383473 |
| 32 | regulation of synapse structural plasticity (GO:0051823) | 4.11154574 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 4.10680368 |
| 34 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.10121285 |
| 35 | synaptic transmission, glutamatergic (GO:0035249) | 4.03184145 |
| 36 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.94619186 |
| 37 | regulation of postsynaptic membrane potential (GO:0060078) | 3.92328613 |
| 38 | potassium ion homeostasis (GO:0055075) | 3.91093166 |
| 39 | potassium ion import (GO:0010107) | 3.90098899 |
| 40 | positive regulation of membrane potential (GO:0045838) | 3.89706261 |
| 41 | long-term memory (GO:0007616) | 3.86956470 |
| 42 | L-amino acid import (GO:0043092) | 3.86523514 |
| 43 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.80970390 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.78434870 |
| 45 | regulation of synaptic plasticity (GO:0048167) | 3.75714801 |
| 46 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.74237122 |
| 47 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71971032 |
| 48 | cellular sodium ion homeostasis (GO:0006883) | 3.71611638 |
| 49 | long-term synaptic potentiation (GO:0060291) | 3.70647692 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.65475250 |
| 51 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.63209543 |
| 52 | neurotransmitter transport (GO:0006836) | 3.63195984 |
| 53 | neuron recognition (GO:0008038) | 3.62212016 |
| 54 | behavioral response to cocaine (GO:0048148) | 3.61068584 |
| 55 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.60248585 |
| 56 | gamma-aminobutyric acid transport (GO:0015812) | 3.57675533 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.56971079 |
| 58 | amino acid import (GO:0043090) | 3.56825722 |
| 59 | presynaptic membrane assembly (GO:0097105) | 3.55957366 |
| 60 | positive regulation of neurotransmitter transport (GO:0051590) | 3.53985257 |
| 61 | cell communication by electrical coupling (GO:0010644) | 3.53662946 |
| 62 | regulation of neurotransmitter secretion (GO:0046928) | 3.52876551 |
| 63 | cellular potassium ion homeostasis (GO:0030007) | 3.52169630 |
| 64 | regulation of dendritic spine development (GO:0060998) | 3.52147232 |
| 65 | response to histamine (GO:0034776) | 3.51849134 |
| 66 | regulation of synapse maturation (GO:0090128) | 3.50809352 |
| 67 | activation of protein kinase A activity (GO:0034199) | 3.50374736 |
| 68 | regulation of vesicle fusion (GO:0031338) | 3.48559851 |
| 69 | regulation of neurotransmitter levels (GO:0001505) | 3.45525143 |
| 70 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.45177381 |
| 71 | mating behavior (GO:0007617) | 3.44887572 |
| 72 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.42850268 |
| 73 | transmission of nerve impulse (GO:0019226) | 3.42359996 |
| 74 | auditory behavior (GO:0031223) | 3.37721510 |
| 75 | prepulse inhibition (GO:0060134) | 3.35253030 |
| 76 | proline transport (GO:0015824) | 3.33070125 |
| 77 | neuromuscular process controlling balance (GO:0050885) | 3.32632928 |
| 78 | regulation of glutamate secretion (GO:0014048) | 3.31502416 |
| 79 | serotonin metabolic process (GO:0042428) | 3.30992505 |
| 80 | regulation of neurotransmitter transport (GO:0051588) | 3.30302580 |
| 81 | synaptic vesicle endocytosis (GO:0048488) | 3.29644415 |
| 82 | positive regulation of synapse maturation (GO:0090129) | 3.28482311 |
| 83 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.28345310 |
| 84 | presynaptic membrane organization (GO:0097090) | 3.28137806 |
| 85 | membrane depolarization (GO:0051899) | 3.25662171 |
| 86 | membrane hyperpolarization (GO:0060081) | 3.25094934 |
| 87 | detection of calcium ion (GO:0005513) | 3.24513278 |
| 88 | membrane depolarization during action potential (GO:0086010) | 3.22841884 |
| 89 | postsynaptic membrane organization (GO:0001941) | 3.21784071 |
| 90 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.20655187 |
| 91 | synaptic transmission, dopaminergic (GO:0001963) | 3.17556830 |
| 92 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.13722566 |
| 93 | intraspecies interaction between organisms (GO:0051703) | 3.13702287 |
| 94 | social behavior (GO:0035176) | 3.13702287 |
| 95 | response to auditory stimulus (GO:0010996) | 3.12891331 |
| 96 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.11907254 |
| 97 | axonal fasciculation (GO:0007413) | 3.11637943 |
| 98 | positive regulation of synaptic transmission (GO:0050806) | 3.08579988 |
| 99 | positive regulation of dendritic spine development (GO:0060999) | 3.07582501 |
| 100 | learning (GO:0007612) | 3.07391146 |
| 101 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.06361033 |
| 102 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.06094016 |
| 103 | regulation of synaptic transmission (GO:0050804) | 3.03607441 |
| 104 | synaptic transmission (GO:0007268) | 3.02733235 |
| 105 | dendritic spine organization (GO:0097061) | 3.02577281 |
| 106 | synapse assembly (GO:0007416) | 3.02097246 |
| 107 | negative regulation of amino acid transport (GO:0051956) | 3.01382019 |
| 108 | regulation of ARF protein signal transduction (GO:0032012) | 3.01215925 |
| 109 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.00138964 |
| 110 | fear response (GO:0042596) | 2.98404870 |
| 111 | cerebellar Purkinje cell layer development (GO:0021680) | 2.98286089 |
| 112 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.98200839 |
| 113 | behavioral fear response (GO:0001662) | 2.97997848 |
| 114 | behavioral defense response (GO:0002209) | 2.97997848 |
| 115 | neuromuscular process controlling posture (GO:0050884) | 2.97793770 |
| 116 | primary amino compound metabolic process (GO:1901160) | 2.97523697 |
| 117 | striatum development (GO:0021756) | 2.93415599 |
| 118 | cell communication involved in cardiac conduction (GO:0086065) | 2.92212930 |
| 119 | neuronal ion channel clustering (GO:0045161) | 2.91917691 |
| 120 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.90537331 |
| 121 | regulation of protein kinase A signaling (GO:0010738) | 2.90479877 |
| 122 | synaptic vesicle transport (GO:0048489) | 2.85875707 |
| 123 | establishment of synaptic vesicle localization (GO:0097480) | 2.85875707 |
| 124 | cell differentiation in hindbrain (GO:0021533) | 2.84882468 |
| 125 | neuromuscular synaptic transmission (GO:0007274) | 2.81101621 |
| 126 | acid secretion (GO:0046717) | 2.80395180 |
| 127 | membrane repolarization (GO:0086009) | 2.78249684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.36642857 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.53703834 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.23788929 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.14516068 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.14262609 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.80298943 |
| 7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.78229664 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.78229664 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74164096 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72297382 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.70279319 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.57516459 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55393769 |
| 14 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54429680 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54226732 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.51070155 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50430404 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31213607 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29550058 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19596008 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.18900575 |
| 22 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15917230 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.14717424 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.06140550 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.97209595 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93337038 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91468803 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81977886 |
| 29 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.81322911 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.80876270 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80774684 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.80653816 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.71844914 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62705531 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61803270 |
| 36 | * CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58712401 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58703755 |
| 38 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54384419 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.54141113 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41736655 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38630309 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37381889 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36659772 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35879099 |
| 45 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.35459397 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33139451 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33081002 |
| 48 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30468805 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30466940 |
| 50 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30463349 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28597137 |
| 52 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22012373 |
| 53 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21873175 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20691589 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19350362 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19321425 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19149003 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18372558 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18041692 |
| 60 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17391132 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17025820 |
| 62 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16202414 |
| 63 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.16195519 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16131568 |
| 65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15581672 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14566848 |
| 67 | AR_19668381_ChIP-Seq_PC3_Human | 1.14018412 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13894585 |
| 69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13009179 |
| 70 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12552120 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12225562 |
| 72 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11416614 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10970970 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08581391 |
| 75 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.07083958 |
| 76 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06827271 |
| 77 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06597940 |
| 78 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.06384670 |
| 79 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06267492 |
| 80 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06052823 |
| 81 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.05154067 |
| 82 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05129573 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03471172 |
| 84 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03331411 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02880422 |
| 86 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.02809346 |
| 87 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02389626 |
| 88 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01726592 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00584081 |
| 90 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00371244 |
| 91 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00150943 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99960052 |
| 93 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98270914 |
| 94 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97964336 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97092496 |
| 96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95725635 |
| 97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95459408 |
| 98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95251567 |
| 99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93175485 |
| 100 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92661024 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90998342 |
| 102 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.90896614 |
| 103 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.90119362 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89674881 |
| 105 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88899211 |
| 106 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88291603 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88126973 |
| 108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88062479 |
| 109 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87584891 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.87584891 |
| 111 | JUN_21703547_ChIP-Seq_K562_Human | 0.87541606 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86709619 |
| 113 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85723448 |
| 114 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85598971 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85372587 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85074589 |
| 117 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84874921 |
| 118 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84480258 |
| 119 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.80944070 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79684251 |
| 121 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.77455259 |
| 122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74021116 |
| 123 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.72994443 |
| 124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.72193413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.59300444 |
| 2 | MP0003880_abnormal_central_pattern | 5.56149398 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.31451535 |
| 4 | MP0009745_abnormal_behavioral_response | 3.66962619 |
| 5 | MP0004270_analgesia | 3.60586445 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.43875884 |
| 7 | MP0002822_catalepsy | 3.42819514 |
| 8 | MP0002064_seizures | 3.34649902 |
| 9 | MP0009046_muscle_twitch | 3.15594155 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.05351018 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.92009990 |
| 12 | MP0001486_abnormal_startle_reflex | 2.72377038 |
| 13 | MP0002272_abnormal_nervous_system | 2.67109113 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.54410328 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.54222350 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.48253622 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.23974084 |
| 18 | MP0002736_abnormal_nociception_after | 2.17946055 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.02790002 |
| 20 | MP0003123_paternal_imprinting | 2.01863162 |
| 21 | MP0002733_abnormal_thermal_nociception | 1.96771019 |
| 22 | MP0002067_abnormal_sensory_capabilities | 1.94984660 |
| 23 | MP0003329_amyloid_beta_deposits | 1.91011974 |
| 24 | MP0001970_abnormal_pain_threshold | 1.91006893 |
| 25 | MP0001529_abnormal_vocalization | 1.85949021 |
| 26 | MP0005386_behavior/neurological_phenoty | 1.85493999 |
| 27 | MP0004924_abnormal_behavior | 1.85493999 |
| 28 | MP0002909_abnormal_adrenal_gland | 1.82978046 |
| 29 | MP0008569_lethality_at_weaning | 1.80047942 |
| 30 | MP0003879_abnormal_hair_cell | 1.77602307 |
| 31 | MP0002735_abnormal_chemical_nociception | 1.75801552 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.72200960 |
| 33 | MP0001905_abnormal_dopamine_level | 1.60969817 |
| 34 | MP0002184_abnormal_innervation | 1.59604382 |
| 35 | MP0001984_abnormal_olfaction | 1.58536878 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.58241462 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.57907810 |
| 38 | MP0006276_abnormal_autonomic_nervous | 1.53708073 |
| 39 | MP0000778_abnormal_nervous_system | 1.51717318 |
| 40 | MP0002066_abnormal_motor_capabilities/c | 1.40803651 |
| 41 | MP0003633_abnormal_nervous_system | 1.38577304 |
| 42 | MP0000955_abnormal_spinal_cord | 1.36918695 |
| 43 | MP0004858_abnormal_nervous_system | 1.36545455 |
| 44 | MP0008872_abnormal_physiological_respon | 1.27990671 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.27351963 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.23666295 |
| 47 | MP0001188_hyperpigmentation | 1.23429459 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.17567923 |
| 49 | MP0005535_abnormal_body_temperature | 1.14426965 |
| 50 | MP0003631_nervous_system_phenotype | 1.13534730 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.12552223 |
| 52 | MP0004885_abnormal_endolymph | 1.11446127 |
| 53 | MP0000566_synostosis | 1.10414109 |
| 54 | MP0004142_abnormal_muscle_tone | 1.10314854 |
| 55 | MP0008874_decreased_physiological_sensi | 1.10033545 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.06173286 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 1.01251949 |
| 58 | MP0003075_altered_response_to | 0.99887059 |
| 59 | MP0002152_abnormal_brain_morphology | 0.98923498 |
| 60 | MP0002069_abnormal_eating/drinking_beha | 0.96537570 |
| 61 | MP0003787_abnormal_imprinting | 0.96295877 |
| 62 | MP0001177_atelectasis | 0.94428919 |
| 63 | MP0003122_maternal_imprinting | 0.93939253 |
| 64 | MP0005409_darkened_coat_color | 0.92413280 |
| 65 | MP0003121_genomic_imprinting | 0.92371662 |
| 66 | MP0000751_myopathy | 0.92314511 |
| 67 | MP0001986_abnormal_taste_sensitivity | 0.90616127 |
| 68 | MP0004742_abnormal_vestibular_system | 0.89409911 |
| 69 | MP0000604_amyloidosis | 0.89362602 |
| 70 | MP0002090_abnormal_vision | 0.88768216 |
| 71 | MP0005645_abnormal_hypothalamus_physiol | 0.88133966 |
| 72 | MP0004085_abnormal_heartbeat | 0.87279745 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 0.85673570 |
| 74 | MP0005551_abnormal_eye_electrophysiolog | 0.85662315 |
| 75 | MP0008961_abnormal_basal_metabolism | 0.85538131 |
| 76 | MP0002229_neurodegeneration | 0.84097442 |
| 77 | MP0003690_abnormal_glial_cell | 0.81706145 |
| 78 | MP0003283_abnormal_digestive_organ | 0.80882627 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.80579628 |
| 80 | MP0001664_abnormal_digestion | 0.79912926 |
| 81 | MP0000920_abnormal_myelination | 0.78622901 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.75511877 |
| 83 | MP0004147_increased_porphyrin_level | 0.73292044 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.73173327 |
| 85 | MP0003632_abnormal_nervous_system | 0.69997670 |
| 86 | MP0005499_abnormal_olfactory_system | 0.69963223 |
| 87 | MP0005394_taste/olfaction_phenotype | 0.69963223 |
| 88 | MP0004484_altered_response_of | 0.69404292 |
| 89 | MP0001346_abnormal_lacrimal_gland | 0.69237657 |
| 90 | MP0000639_abnormal_adrenal_gland | 0.68418102 |
| 91 | MP0004043_abnormal_pH_regulation | 0.67926661 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.67914795 |
| 93 | MP0000569_abnormal_digit_pigmentation | 0.67345527 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.67050427 |
| 95 | MP0004510_myositis | 0.66712366 |
| 96 | MP0004215_abnormal_myocardial_fiber | 0.66034408 |
| 97 | MP0000026_abnormal_inner_ear | 0.65721368 |
| 98 | MP0003634_abnormal_glial_cell | 0.64833040 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.63272051 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.62871562 |
| 101 | MP0003938_abnormal_ear_development | 0.62247610 |
| 102 | MP0008877_abnormal_DNA_methylation | 0.61898577 |
| 103 | MP0001299_abnormal_eye_distance/ | 0.59435764 |
| 104 | MP0002752_abnormal_somatic_nervous | 0.59403727 |
| 105 | MP0003861_abnormal_nervous_system | 0.57404404 |
| 106 | MP0001943_abnormal_respiration | 0.57348234 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.57206175 |
| 108 | MP0009379_abnormal_foot_pigmentation | 0.56320138 |
| 109 | MP0004130_abnormal_muscle_cell | 0.54389720 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.53969501 |
| 111 | MP0003183_abnormal_peptide_metabolism | 0.53248280 |
| 112 | MP0005623_abnormal_meninges_morphology | 0.51416372 |
| 113 | MP0003137_abnormal_impulse_conducting | 0.51327282 |
| 114 | MP0003956_abnormal_body_size | 0.49398345 |
| 115 | MP0005166_decreased_susceptibility_to | 0.47750016 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.46992086 |
| 117 | MP0010769_abnormal_survival | 0.46652998 |
| 118 | MP0010770_preweaning_lethality | 0.46050496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.66189678 |
| 2 | Myokymia (HP:0002411) | 6.87595339 |
| 3 | Focal seizures (HP:0007359) | 6.24791565 |
| 4 | Visual hallucinations (HP:0002367) | 5.62052182 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.39038576 |
| 6 | Atonic seizures (HP:0010819) | 5.18623233 |
| 7 | Absence seizures (HP:0002121) | 4.71279363 |
| 8 | Febrile seizures (HP:0002373) | 4.46425111 |
| 9 | Dialeptic seizures (HP:0011146) | 4.27885782 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 4.24675802 |
| 11 | Hyperventilation (HP:0002883) | 4.09455784 |
| 12 | Poor eye contact (HP:0000817) | 4.02827465 |
| 13 | Broad-based gait (HP:0002136) | 4.00563593 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.87886677 |
| 15 | Impaired social interactions (HP:0000735) | 3.56922184 |
| 16 | Abnormal social behavior (HP:0012433) | 3.56922184 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 3.54490636 |
| 18 | Amblyopia (HP:0000646) | 3.51562945 |
| 19 | Action tremor (HP:0002345) | 3.49928410 |
| 20 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.41921084 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.30617493 |
| 22 | Papilledema (HP:0001085) | 3.29385000 |
| 23 | Anxiety (HP:0000739) | 3.26712955 |
| 24 | Depression (HP:0000716) | 3.20176017 |
| 25 | Dysmetria (HP:0001310) | 3.17751419 |
| 26 | Ankle clonus (HP:0011448) | 3.14413014 |
| 27 | Truncal ataxia (HP:0002078) | 2.99829507 |
| 28 | Supranuclear gaze palsy (HP:0000605) | 2.99821424 |
| 29 | Akinesia (HP:0002304) | 2.99392240 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.99374882 |
| 31 | Abnormal eating behavior (HP:0100738) | 2.89775064 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 2.89399042 |
| 33 | Stereotypic behavior (HP:0000733) | 2.84935826 |
| 34 | Postural instability (HP:0002172) | 2.76446885 |
| 35 | Neurofibrillary tangles (HP:0002185) | 2.76120976 |
| 36 | Scanning speech (HP:0002168) | 2.73364890 |
| 37 | Impaired smooth pursuit (HP:0007772) | 2.72810077 |
| 38 | Status epilepticus (HP:0002133) | 2.72581094 |
| 39 | Epileptiform EEG discharges (HP:0011182) | 2.70948083 |
| 40 | Sleep apnea (HP:0010535) | 2.70633546 |
| 41 | Limb dystonia (HP:0002451) | 2.70611154 |
| 42 | Urinary urgency (HP:0000012) | 2.64930916 |
| 43 | Cerebral hypomyelination (HP:0006808) | 2.63815326 |
| 44 | EEG with generalized epileptiform discharges (HP:0011198) | 2.61135032 |
| 45 | Drooling (HP:0002307) | 2.60650889 |
| 46 | Excessive salivation (HP:0003781) | 2.60650889 |
| 47 | Torticollis (HP:0000473) | 2.58305666 |
| 48 | Hemiparesis (HP:0001269) | 2.55434694 |
| 49 | Absent speech (HP:0001344) | 2.52741925 |
| 50 | Inability to walk (HP:0002540) | 2.52556842 |
| 51 | Annular pancreas (HP:0001734) | 2.48492654 |
| 52 | Bradykinesia (HP:0002067) | 2.46361410 |
| 53 | Spastic gait (HP:0002064) | 2.46087624 |
| 54 | Progressive inability to walk (HP:0002505) | 2.44325947 |
| 55 | Focal dystonia (HP:0004373) | 2.41360564 |
| 56 | Hypsarrhythmia (HP:0002521) | 2.41084595 |
| 57 | Impaired vibratory sensation (HP:0002495) | 2.38578944 |
| 58 | Dysmetric saccades (HP:0000641) | 2.37963240 |
| 59 | Intention tremor (HP:0002080) | 2.35217523 |
| 60 | Generalized myoclonic seizures (HP:0002123) | 2.34548618 |
| 61 | Increased circulating renin level (HP:0000848) | 2.33865974 |
| 62 | Pheochromocytoma (HP:0002666) | 2.33439360 |
| 63 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.33336353 |
| 64 | Genetic anticipation (HP:0003743) | 2.31309308 |
| 65 | Abnormality of the lower motor neuron (HP:0002366) | 2.29988869 |
| 66 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.26042281 |
| 67 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.26042281 |
| 68 | Resting tremor (HP:0002322) | 2.25495899 |
| 69 | Mutism (HP:0002300) | 2.22468673 |
| 70 | Abnormality of binocular vision (HP:0011514) | 2.22324174 |
| 71 | Diplopia (HP:0000651) | 2.22324174 |
| 72 | Termporal pattern (HP:0011008) | 2.21207970 |
| 73 | Insidious onset (HP:0003587) | 2.21207970 |
| 74 | Craniofacial dystonia (HP:0012179) | 2.20923844 |
| 75 | Tetraplegia (HP:0002445) | 2.20589629 |
| 76 | Spastic tetraparesis (HP:0001285) | 2.18939759 |
| 77 | Hemiplegia (HP:0002301) | 2.18402099 |
| 78 | Delusions (HP:0000746) | 2.17951235 |
| 79 | Blue irides (HP:0000635) | 2.16796789 |
| 80 | Megalencephaly (HP:0001355) | 2.16119834 |
| 81 | Ventricular fibrillation (HP:0001663) | 2.15668177 |
| 82 | Fetal akinesia sequence (HP:0001989) | 2.15077176 |
| 83 | Gait ataxia (HP:0002066) | 2.12985806 |
| 84 | Insomnia (HP:0100785) | 2.10137898 |
| 85 | Ankyloglossia (HP:0010296) | 2.06678282 |
| 86 | Protruding tongue (HP:0010808) | 2.05881241 |
| 87 | Peripheral hypomyelination (HP:0007182) | 2.01284504 |
| 88 | Neuroendocrine neoplasm (HP:0100634) | 2.00336122 |
| 89 | Lower limb muscle weakness (HP:0007340) | 1.99033553 |
| 90 | Lower limb asymmetry (HP:0100559) | 1.98729536 |
| 91 | Apathy (HP:0000741) | 1.97807241 |
| 92 | Bronchomalacia (HP:0002780) | 1.96032179 |
| 93 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.93756393 |
| 94 | Agitation (HP:0000713) | 1.92961916 |
| 95 | Incomplete penetrance (HP:0003829) | 1.92909329 |
| 96 | Abnormality of the periventricular white matter (HP:0002518) | 1.90515716 |
| 97 | Rigidity (HP:0002063) | 1.87937140 |
| 98 | Psychosis (HP:0000709) | 1.86819224 |
| 99 | Syncope (HP:0001279) | 1.85627250 |
| 100 | Prolonged QT interval (HP:0001657) | 1.85605221 |
| 101 | Clumsiness (HP:0002312) | 1.85480085 |
| 102 | Choreoathetosis (HP:0001266) | 1.85101486 |
| 103 | Abnormality of salivation (HP:0100755) | 1.83138233 |
| 104 | Polyphagia (HP:0002591) | 1.82534311 |
| 105 | Clonus (HP:0002169) | 1.80671168 |
| 106 | Hyperthyroidism (HP:0000836) | 1.80200633 |
| 107 | Generalized hypopigmentation of hair (HP:0011358) | 1.79937698 |
| 108 | Abnormal EKG (HP:0003115) | 1.78022749 |
| 109 | Diminished motivation (HP:0000745) | 1.77447748 |
| 110 | Pointed chin (HP:0000307) | 1.77349757 |
| 111 | Thickened helices (HP:0000391) | 1.77076013 |
| 112 | Metabolic alkalosis (HP:0200114) | 1.76966788 |
| 113 | Spastic tetraplegia (HP:0002510) | 1.76142248 |
| 114 | Obstructive sleep apnea (HP:0002870) | 1.74925041 |
| 115 | Lower limb amyotrophy (HP:0007210) | 1.74034462 |
| 116 | Abnormality of the corticospinal tract (HP:0002492) | 1.73857576 |
| 117 | Abnormality of saccadic eye movements (HP:0000570) | 1.73313963 |
| 118 | Rapidly progressive (HP:0003678) | 1.73031739 |
| 119 | Neuronal loss in central nervous system (HP:0002529) | 1.69446547 |
| 120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.68377544 |
| 121 | Spinal canal stenosis (HP:0003416) | 1.63453409 |
| 122 | Diminished movement (HP:0002374) | 1.61091126 |
| 123 | CNS hypomyelination (HP:0003429) | 1.60625574 |
| 124 | Split foot (HP:0001839) | 1.60533951 |
| 125 | Hypoventilation (HP:0002791) | 1.59626597 |
| 126 | Aplasia of the phalanges of the hand (HP:0009802) | 1.58562882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.48688055 |
| 2 | NTRK3 | 4.23571584 |
| 3 | MAP3K9 | 3.73794163 |
| 4 | DAPK2 | 3.33929657 |
| 5 | RIPK4 | 3.01452563 |
| 6 | MAP3K4 | 2.79932859 |
| 7 | MAP2K7 | 2.34758461 |
| 8 | KSR2 | 2.31745210 |
| 9 | MAP3K12 | 2.29231860 |
| 10 | MINK1 | 2.29056195 |
| 11 | PAK6 | 2.15724250 |
| 12 | PNCK | 2.02669472 |
| 13 | MAP2K4 | 1.96439117 |
| 14 | PRKD3 | 1.95703889 |
| 15 | DAPK1 | 1.93713413 |
| 16 | NTRK1 | 1.93445148 |
| 17 | CAMKK1 | 1.89213254 |
| 18 | CASK | 1.82671856 |
| 19 | PLK2 | 1.72674274 |
| 20 | MARK1 | 1.71181338 |
| 21 | NTRK2 | 1.68133986 |
| 22 | ARAF | 1.64045637 |
| 23 | SIK2 | 1.63024774 |
| 24 | KSR1 | 1.57546692 |
| 25 | CDK5 | 1.53698604 |
| 26 | MAP3K13 | 1.49088628 |
| 27 | GRK5 | 1.48894693 |
| 28 | TNIK | 1.38659451 |
| 29 | CDK19 | 1.37992283 |
| 30 | BMPR2 | 1.30976138 |
| 31 | MAP3K2 | 1.30612415 |
| 32 | FES | 1.27235122 |
| 33 | CAMKK2 | 1.25751183 |
| 34 | CCNB1 | 1.20509122 |
| 35 | PRKCG | 1.15498050 |
| 36 | TYRO3 | 1.10786568 |
| 37 | UHMK1 | 1.10266651 |
| 38 | STK38 | 1.10232534 |
| 39 | RAF1 | 1.02680564 |
| 40 | RIPK1 | 1.01941076 |
| 41 | CAMK2A | 1.00060389 |
| 42 | PRPF4B | 0.98788607 |
| 43 | LIMK1 | 0.96143552 |
| 44 | PTK2B | 0.94118970 |
| 45 | MAPK13 | 0.93094192 |
| 46 | CAMK1 | 0.91312684 |
| 47 | TAOK1 | 0.90752648 |
| 48 | OXSR1 | 0.88622445 |
| 49 | STK11 | 0.86460540 |
| 50 | RET | 0.85756503 |
| 51 | CAMK2B | 0.85574354 |
| 52 | CDK18 | 0.85137562 |
| 53 | CDK15 | 0.84305976 |
| 54 | CDK14 | 0.82472146 |
| 55 | MAP3K1 | 0.77782475 |
| 56 | PINK1 | 0.75724762 |
| 57 | SGK223 | 0.74695252 |
| 58 | SGK494 | 0.74695252 |
| 59 | CDK11A | 0.73385779 |
| 60 | MAPKAPK5 | 0.73379760 |
| 61 | PDPK1 | 0.71212285 |
| 62 | SGK1 | 0.70473522 |
| 63 | PKN1 | 0.69075538 |
| 64 | PAK3 | 0.65861285 |
| 65 | PRKCH | 0.65603320 |
| 66 | DAPK3 | 0.65333815 |
| 67 | PDK1 | 0.65159490 |
| 68 | LATS2 | 0.63757669 |
| 69 | FGR | 0.62507909 |
| 70 | CSNK1G2 | 0.62345809 |
| 71 | BRSK1 | 0.61916222 |
| 72 | SGK2 | 0.60580070 |
| 73 | NME1 | 0.60333752 |
| 74 | MAP3K11 | 0.59104565 |
| 75 | AKT3 | 0.57826506 |
| 76 | TESK1 | 0.57057961 |
| 77 | TNK2 | 0.56982679 |
| 78 | CAMK1G | 0.54600570 |
| 79 | CAMK2D | 0.53512294 |
| 80 | WNK1 | 0.51410506 |
| 81 | MAP2K1 | 0.50580038 |
| 82 | CAMK2G | 0.50025746 |
| 83 | SGK3 | 0.47797836 |
| 84 | PRKCE | 0.47172477 |
| 85 | MARK2 | 0.46211680 |
| 86 | RPS6KA3 | 0.45481683 |
| 87 | DYRK1A | 0.44905128 |
| 88 | ERBB2 | 0.43884301 |
| 89 | PRKG2 | 0.43692804 |
| 90 | PRKCZ | 0.43509705 |
| 91 | ALK | 0.42661879 |
| 92 | PTK2 | 0.41673269 |
| 93 | ROCK2 | 0.40055144 |
| 94 | LMTK2 | 0.39982755 |
| 95 | PIK3CA | 0.39904861 |
| 96 | MAPK12 | 0.38950453 |
| 97 | DMPK | 0.38358053 |
| 98 | CAMK4 | 0.38279647 |
| 99 | BRAF | 0.37605381 |
| 100 | CSNK1E | 0.37132754 |
| 101 | FYN | 0.36079793 |
| 102 | MAPK10 | 0.35709193 |
| 103 | WNK4 | 0.35383897 |
| 104 | PRKG1 | 0.35150541 |
| 105 | PHKG1 | 0.34893451 |
| 106 | PHKG2 | 0.34893451 |
| 107 | MAP3K7 | 0.34675570 |
| 108 | MAPK7 | 0.34244858 |
| 109 | NEK6 | 0.34228784 |
| 110 | PRKD2 | 0.33469434 |
| 111 | FGFR2 | 0.32846030 |
| 112 | PRKACA | 0.32169349 |
| 113 | MOS | 0.31487454 |
| 114 | PRKCB | 0.29215774 |
| 115 | MAP3K6 | 0.28973740 |
| 116 | FER | 0.28774361 |
| 117 | STK39 | 0.28635589 |
| 118 | PRKCA | 0.28574594 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.64159741 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.30481788 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.85385000 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.79036657 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.76931021 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.74558400 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.63793436 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.62987246 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62112196 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.51526454 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.28971473 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.26525902 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.06915470 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.05273155 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.97766299 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.96932877 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.93169209 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.92003490 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.86848441 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.77239982 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.76507954 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.75059237 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.74350493 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.72349174 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69632291 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64094644 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.51932923 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49679146 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.41915626 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.35960956 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32936804 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23407775 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20581054 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.18256074 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.17379302 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15799365 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10963419 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.08332688 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06537685 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05026878 |
| 41 | Melanogenesis_Homo sapiens_hsa04916 | 1.04679024 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03956998 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03632955 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.03299825 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00145136 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91584710 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90970303 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89919127 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 0.88212008 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85872132 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84449377 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82952865 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.82859741 |
| 54 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82818467 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80665480 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 0.80585717 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77466771 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75223713 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72535900 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72205143 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69196709 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67679194 |
| 63 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67406002 |
| 64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67007124 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66158795 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64352746 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63539198 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59372569 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58545743 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54816690 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53869015 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52546795 |
| 73 | Alcoholism_Homo sapiens_hsa05034 | 0.50220786 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.49724265 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49068444 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49025272 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.48795456 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48375658 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48008107 |
| 80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.47668576 |
| 81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47347746 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46757768 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45782678 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44848487 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42951828 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41122151 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40116818 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38984051 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38939879 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37861555 |
| 91 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37029928 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35695349 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35158476 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34693621 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34686266 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33488829 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.32958897 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32529913 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32319557 |
| 100 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.31128185 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.30865606 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30353555 |
| 103 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29704722 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29410305 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29365663 |
| 106 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.28547847 |
| 107 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28206178 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26950205 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26900572 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26800788 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.24011843 |
| 112 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.23527607 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.22677817 |
| 114 | Huntingtons disease_Homo sapiens_hsa05016 | 0.21688690 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21476085 |

